IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option

NORTH HOLLYWOOD, Calif., Feb. 5 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM ), a leading provider of hospitalist services, today announced that it closed its previously announced initial public offering of 5,200,000 shares on January 30, 2008 and that the underwr...

F. Duwaine Townsen Joins SpectraScience Board of Directors

...oratories, Inc., a medical device company, as Chief Financial Officer. He was appointed to CEO and Chairman in 1974 and guided the Company through its ipo in 1978 and sale to American Hospital Supply Corporation in 1981. In 1982, Mr. Townsen co-founded the Ventana Growth Funds, a group of four ve...

Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing

... under his leadership Adams completed its initial public offering in July 2005, which was ranked by The Wall Street Journal as the No. 1 Health Care ipo in 2005. In January 2008, he successfully led the sale of the company to Reckitt Benckiser for $2.3B. Mr. Valentino said, "I look forward to w...

U.S. Venture Investment Lowest in 11 Years, Down 50% to $3.9 Billion in First Quarter

...al count since 1995. "Technology companies have long been the primary focus of venture capitalists," said Ms. Canning. "But with a non-existent ipo market and corporations paying less for venture-backed technologies, the incentive for investors to back new or unproven business models is just not t...

DecisionView Board of Directors Appoints James P. Scullion as CEO and President

...ding provider of criminal intelligence systems. During Mr. Scullion's tenure at ComnetiX, revenues grew threefold and he led the company's successful ipo on the Toronto Stock Exchange. From 1990 to 2002, he held senior management positions including President and COO with Identix Incorporated, a public...

Alexandria Real Estate Equities Provides Update

...ith both real estate and life science operating experience and expertise, set Alexandria apart from all other publicly-traded REITs. From Alexandria's ipo (May 1997) through December 31, 2008, Alexandria ranked number four of all publicly-traded equity REIT with a total return of 399% (assuming reinvestm...

Santa Monica Media Corporation Files Extension Proxy With SEC to Complete Transaction

...2009, Santa Monica Media Corporation (NYSE Alternext US: MEJ, MEJ.U, MEJ.WS) ("SMMC"), a special purpose acquisition company (SPAC) that completed its ipo in April 2007 filed a preliminary proxy statement with the Securities Exchange Commission ("SEC") relating to a special meeting of its stockholders sc...

Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009

...es outstanding, including net benefits resulting primarily from the recognition of deferred tax assets during the year. The Company completed its ipo on November 2, 2007. On a pro forma basis, assuming conversion of all outstanding preferred stock, diluted EPS for the quarter and year ended Decembe...

XIFIN Inc. Expands Its Executive Management Team

... positions at Aspect Medical Systems, Behring Diagnostics, and Boston Scientific. Mr. Zaniboni's experience includes raising over $500 million through ipo proceeds for high growth healthcare companies. He holds a B.S. in accounting from Boston University and an M.B.A. from Boston College . R. Wil...

China Healthcare Acquisition Announces Record Date for Trust Fund Distribution

...s from the trust fund established by the Company at the consummation of its initial public offering (the "IPO") and into which the net proceeds of the ipo were deposited. The Company has instructed its transfer agent, American Stock Transfer & Trust Company, to close its stock transfer books as of t...

More>>

IPO in Biological Technology

Sucampo Pharmaceuticals Announces Exercise and Closing of IPO Over-Allotment Option

BETHESDA, Md., Aug. 29 /PRNewswire-FirstCall/ -- Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP ) today announced that the underwriters for its initial public offering have exercised in full their option to purchase 562,500 shares of Sucampo's class A common stock to cover over-allotments and th...

The IPO Window Cracks

SAN MATEO, CA - With the children now back in school and a general air of a "new year" upon us, we have the opportunity to demonstrate that the grownups have learned a few lessons from the pain of the economic crunch. Over the next few weeks, a number of courageous souls will take their compani...

TomoTherapy considers IPO with medical-device business on the rise

A technology that could bring better, safer treatments to cancer patients worldwide might have fallen through the cracks. Now Tomotherapy, a Madison medical-device firm with more than 200 employees that has grown to $44 million in sales, could go public within a year, its founder said. The compa...

Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says

CHICAGO Anyone following this column over the last few years knows about my propensity for lists. These lists allow me to arrange information into tidy boxes in some meaningful order for others (or at least to make better sense out of the information for myself). While my list propensity didn...

TomoTherapy revises IPO money target

Madison, Wis . - TomoTherapy has filed an amended registration statement with the U.S. Securities and Exchange Commission , raising to $213 million the amount it could raise in its pending initial pubic offering of stock. While there is still no date for the IPO, the company expected the o...

NimbleGen to discontinue IPO after Roche's $272.5 million acquisition

Madison, Wis. - NimbleGen Systems , a manufacturer of gene chips for pharmaceutical research, will discontinue its work toward an initial public offering of stock following its acquisition by Roche , the Basel, Switzerland based pharmaceutical giant. NimbleGen had sought to raise $75 million...

Cash-rich TomoTherapy has no plans for IPO

Madison, Wis. - TomoTherapy, Inc. , the medical device developer that has secured $42 million in outside equity and has rapidly grown sales of its precision radiation therapy technology based on the innovations of University of Wisconsin-Madison researchers, is riding high. So high that it ...

TomoTherapy files registration statement for IPO

Madison, Wis. - TomoTherapy, Inc. has filed a registration statement with the Securities and Exchange Commission for an initial public offering of common stock. The Madison-based medical device manufacturer has filed a Form S-1 to sell shares on the NASDAQ Global Market . The number ...

TomoTherapy raises $223 million in IPO

Madison, Wis .- TomoTherapy has raised $223 million, the amount it had hoped to raise, in an initial public offering that was completed earlier today. TomoTherapy, a portfolio company of Baird Venture Partners I , offered common stock at $19 per share, and expects to receive $185 million in ...

Burrill & Company Invests in Taiwan Liposome Company

...ence Venture Corp., and other earlier investors. The proceeds will serve to advance the development of its lead product and prepare the company for an ipo in Taiwan. About Taiwan Liposome Company Incorporated in 1997, Taiwan Liposome Company is a biopharmaceutical company engaging in research, dev...

More>>